SUMMARY At necropsy five of eight patients (mean age 57 years) who died after intravenous streptokinase treatment for severe acute myocardial infarction (mean Peel index = 18) were found to have a patent infarct related coronary artery. Coronary artery stenoses were caused by fibrofatty atheromatous plaques; there were no residual thrombi in the lumen or acute intimal lesions. Three ofthese infarcts were ofpartial thickness (less than two thirds wall width) with sparing of the outer third of the myocardium and subendocardial zones. In the other three patients the infarct related coronary arteries remained histologically closed with residual lumen thrombi and underlying intimal lesions. Two infarcts were transmural. Six of the eight infarcts were noticeably haemorrhagic. Myocardial haemorrhage was confined to areas ofnecrotic myocardium and did not affect viable regions.
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These findings suggest that thrombus overlying a complex lesion may be more difficult to lyse than thrombus overlying a simple fibrofatty plaque. They also suggest that myocardial haemorrhage outside the infarct area, which might lead to cardiac rupture or delayed healing, does not usually occur. There has been relatively little reported work on human cardiac pathology after thrombolytic treatment and several points are not clear. Myocardial haemorrhage may occur after coronary reperfusion. Although the weight of evidence suggests that this only occurs in areas of irreversibly damaged myocardium, fatal haemorrhagic myocardial infarction has been described after intracoronary streptokinase treatment.12 It has also been suggested that the success of coronary artery recanalisation depends, in part, on the morphologic features of the coronary occlusion and that reperfusion after successful thrombolysis may lead to a different pattern of muscle fibre necrosis in the irreversibly injured infarct areas.'
The aims of this study were to characterise the changes in the myocardium after streptokinase treatment and to determine whether streptokinase treatment directly contributed to mortality in any patient. Accepted for publication 2 February 1989 underlying coronary lesion and to the extent of myocardial damage.
Patients and methods
Over a 15 month period necropsies were performed on eight patients who died after receiving thrombolytic treatment for acute myocardial infarction.
Patients less than 70 were treated with 1-5 million units of streptokinase intravenously if they had chest pain lasting < 6 h, typical ST segment elevation of at least 2 mm in the precordial chest leads or 1 patients myocardial infarction was of partial wall thickness (fig 3) . One case showed a transmural myocardial infarction and one a mixed picture with areas of both partial thickness and transmural myocardial infarction. Two of the three patients with an occluded infarct related artery were associated with transmural myocardial infarction and one with a partial thickness infarct (table 3) .
Histological examination confirmed the haemor- These thrombi probably originated from the fragmenting proximal obstructive thrombus (fig 4) .
Discussion
The potential reduction of myocardial infarct size by thrombolysis and other treatments has been the subject of much interest in recent years. 6 Clinical trials have shown both an improvement in hospital mortality7 and left ventricular function8 after intravenous streptokinase treatment. Histopathological evidence of myocardial salvage after coronary reperfusion has mainly come from experimental coronary reperfusion in dogs910 and there has been relatively little published work in human beings. This experimental work has shown that a wavefront of ischaemic necrosis progresses from subendocardial myocardium to subepicardial myocardium over a period of several hours. Coronary reperfusion after release of the arterial ligatures halted the progression of this ischaemic wavefront, with salvage of the subepicardial myocardium. The extent ofmyocardial necrosis was related to the duration of coronary occlusion.
The results of the present study showed a trend towards the occurrence ofpartial thickness infarction in patients with an open infarct related coronary artery, and transmural infarction in patients with a closed infarct related coronary artery. None the less, we cannot reach any direct conclusions about myocardial salvage after streptokinase treatment. The number of cases examined was small and neither the degree of collateral circulation nor the size of the infarct bed at risk could be adequately assessed. Rentrop et al reported on 10 patients who had aortocoronary bypass grafting after intracoronary streptokinase treatment." Intraoperative inspection showed that the bulk of the reperfused myocardium was viable, and biopsy specimens from three patients showed damage only in the subendocardial region. In partial thickness myocardial infarcts Mattfeldt et al described the presence of contraction band necrosis due to aggregation of myofibre sarcomeres caused by reperfusion of irreversibly damaged myocytes.3 This is different from the usual coagulative necrosis seen in the myocardium after permanent coronary occlusion. Contraction band necrosis was seen in the present study but also occurred in two of the three patients with a persistently occluded infarct related coronary artery as well as in four of the five patients with an open infarct related coronary artery. This suggests that contraction band necrosis is not solely a consequence of myocardial reperfusion.
The success of coronary artery recanalisation has been related to the complexity of the atheromatous occlusion.' In this study, four ofthe five patients with a patent infarct related coronary artery had a simple fibrofatty plaque. In the fifth patient a simple lesion may have been complicated by postinfarction coron-Pathological changes after intravenous streptokinase treatment in acute myocardial infarction 395 ary angioplasty. In contrast, a complicated atheromatous stenosis with an acute intimal lesion was shown in all three patients with persistent coronary artery occlusion. This suggests that thrombus associated with a non-complicated lesion may be more easily lysed than thrombus overlying a complex mural lesion. The ease of clot dissolution, however, may also be related to the degree of atheromatous stenosis, which was greater in the complex lesions.
Terrosu et al studied the angiographic appearance of the coronary arteries during successful thrombolytic treatment."2 They found that total coronary occlusion was followed by the restoration of blood flow but with intraluminal filling defects and delayed distal flow possibly due to microembolism. We found intramyocardial microembolism in two of our patients. It is possible that microembolism may limit the benefits of thrombolysis by reducing blood flow through the distal coronary circulation.
The association between streptokinase treatment and haemorrhagic myocardial infarction has previously been noted and has even been held to be responsible for myocardial rupture.'2 Haemorrhagic infarction was seen in six of our patients. Haemorrhage occurred into areas of myocardial necrosis and did not extend beyond the infarct into viable myocardium. The presence of infarct haemorrhage was not obviously responsible for complications in our study. This supports the results of experimental studies in dogs. These indicated that reperfusion haemorrhage occurs as a result of the microvascular damage that follows and it is never greater than the extent of myocardial necrosis."' 4 Whether myocardial haemorrhage has any long term deleterious clinical effects remains uncertain. One encouraging report has shown that collagen formation is not delayed in haemorrhagic reperfused myocardial infarcts in dogs. '5 Swelling, degeneration, and separation of endothelial cells may lead to microvascular obstruction and the "no-reflow" effect after reperfusion.'6 This may have been important in patient 3 who had a transmural infarct despite a patent infarct related coronary artery. Myocardial haemorrhage was common after coronary reperfusion but occurred into areas of already irreversibly damaged myocardium and did not contribute to the death of any patient. The success ofcoronary artery reperfusion may be related to the complexity and degree of the underlying atheromatous lesion.
